MundiPharma & Han Wha Pharma signs co-marketing agreement of Gynobetadine
M
undiPharma(CEO Myung-Sae Lee) and Han Wha Pharma(CEO Kyung-Rak Kim) announced on the 7th of February that they signed a joint sales agreement of Gynobetadine Vag Supp(50 suppositories per package), the most well-known vaginitis treatment in Korea.
Under the agreement, Hwan Wha Pharma will take ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
